AAPL289.85+0.49 (+0.17%) ▲|ABBV249.67-1.97 (-0.78%) ▼|ABT92.66+1.92 (+2.11%) ▲|ACN126.81+2.37 (+1.90%) ▲|ADBE208.69+3.67 (+1.79%) ▲|AMAT688.39-34.62 (-4.79%) ▼|AMD560.27-20.64 (-3.55%) ▼|AMGN362.83+0.71 (+0.19%) ▲|AMT165.40+1.83 (+1.12%) ▲|AMZN236.24-2.11 (-0.88%) ▼|AVGO370.19-7.56 (-2.00%) ▼|AXP339.32+1.07 (+0.32%) ▲|BA218.29+1.82 (+0.84%) ▲|BAC57.45+0.47 (+0.82%) ▲|BKNG180.02+1.78 (+1.00%) ▲|BLK964.15+2.59 (+0.27%) ▲|BMY57.22-0.40 (-0.69%) ▼|BNY145.09+0.48 (+0.33%) ▲|BRK-B500.49+0.10 (+0.02%) ▲|C139.12-0.84 (-0.60%) ▼|CAT1,038.13-26.77 (-2.51%) ▼|CL91.78+0.10 (+0.11%) ▲|CMCSA24.00-0.56 (-2.26%) ▼|COF202.06+1.44 (+0.72%) ▲|COP104.00+0.04 (+0.04%) ▲|COST925.00-10.47 (-1.12%) ▼|CRM163.56+6.90 (+4.40%) ▲|CSCO116.72-0.74 (-0.63%) ▼|CVS103.58+0.13 (+0.13%) ▲|CVX166.48+0.72 (+0.43%) ▲|DE625.06-9.27 (-1.46%) ▼|DHR191.76+1.28 (+0.67%) ▲|DIS97.00+0.75 (+0.77%) ▲|DUK126.33-0.25 (-0.20%) ▼|EMR141.55-1.61 (-1.12%) ▼|FDX315.28+2.15 (+0.69%) ▲|GD359.74+5.50 (+1.55%) ▲|GE374.75+1.02 (+0.27%) ▲|GEV1,151.69-23.17 (-1.97%) ▼|GILD125.78-0.56 (-0.44%) ▼|GM77.20+0.12 (+0.16%) ▲|GOOG353.82+0.49 (+0.14%) ▲|GOOGL357.16-0.22 (-0.06%) ▼|GS1,016.00+4.63 (+0.46%) ▲|HD354.31+1.63 (+0.46%) ▲|HON224.85+0.95 (+0.42%) ▲|IBM286.68+5.47 (+1.95%) ▲|INTC135.25-4.38 (-3.14%) ▼|INTU270.82+9.82 (+3.76%) ▲|ISRG401.82+4.14 (+1.04%) ▲|JNJ252.95-1.02 (-0.40%) ▼|JPM328.29+0.96 (+0.29%) ▲|KO81.62+0.35 (+0.42%) ▲|LIN519.07+0.13 (+0.02%) ▲|LLY1,195.38-4.05 (-0.34%) ▼|LMT518.83+9.37 (+1.84%) ▲|LOW223.16+2.67 (+1.21%) ▲|LRCX408.21-25.12 (-5.80%) ▼|MA514.50+0.90 (+0.18%) ▲|MCD269.55-0.76 (-0.28%) ▼|MDLZ58.72+0.88 (+1.52%) ▲|MDT79.54+1.31 (+1.67%) ▲|META604.43+41.14 (+7.30%) ▲|MMM160.68-1.23 (-0.76%) ▼|MO72.15+0.20 (+0.28%) ▲|MRK126.86-1.64 (-1.28%) ▼|MS209.85+0.81 (+0.39%) ▲|MSFT376.53+3.51 (+0.94%) ▲|MU1,089.58-64.71 (-5.61%) ▼|NEE87.36-0.37 (-0.42%) ▼|NFLX72.72+1.32 (+1.85%) ▲|NKE42.12+1.08 (+2.62%) ▲|NOW102.66+3.39 (+3.41%) ▲|NVDA195.25-4.84 (-2.42%) ▼|ORCL145.70-0.96 (-0.65%) ▼|PEP139.18+3.78 (+2.79%) ▲|PFE24.11+0.33 (+1.37%) ▲|PG146.41-0.11 (-0.08%) ▼|PLTR123.25+6.58 (+5.64%) ▲|PM179.11-1.74 (-0.96%) ▼|QCOM184.51-0.29 (-0.15%) ▼|RTX189.98+0.32 (+0.17%) ▲|SBUX102.45+0.26 (+0.25%) ▲|SCHW93.35+1.15 (+1.25%) ▲|SO95.66-0.03 (-0.03%) ▼|SPG221.57-2.15 (-0.96%) ▼|T20.81+0.12 (+0.56%) ▲|TMO505.28+4.37 (+0.87%) ▲|TMUS170.88+3.15 (+1.88%) ▲|TSLA422.87+2.27 (+0.54%) ▲|TXN302.33+4.26 (+1.43%) ▲|UBER72.75+0.64 (+0.89%) ▲|UNH418.13+2.78 (+0.67%) ▲|UNP272.74+0.84 (+0.31%) ▲|UPS108.25+0.85 (+0.79%) ▲|USB60.96+0.55 (+0.90%) ▲|V342.20-0.39 (-0.11%) ▼|VZ42.38+0.07 (+0.17%) ▲|WFC84.21+1.57 (+1.90%) ▲|WMT107.91-5.35 (-4.72%) ▼|XOM137.00+0.52 (+0.38%) ▲|AAPL289.85+0.49 (+0.17%) ▲|ABBV249.67-1.97 (-0.78%) ▼|ABT92.66+1.92 (+2.11%) ▲|ACN126.81+2.37 (+1.90%) ▲|ADBE208.69+3.67 (+1.79%) ▲|AMAT688.39-34.62 (-4.79%) ▼|AMD560.27-20.64 (-3.55%) ▼|AMGN362.83+0.71 (+0.19%) ▲|AMT165.40+1.83 (+1.12%) ▲|AMZN236.24-2.11 (-0.88%) ▼|AVGO370.19-7.56 (-2.00%) ▼|AXP339.32+1.07 (+0.32%) ▲|BA218.29+1.82 (+0.84%) ▲|BAC57.45+0.47 (+0.82%) ▲|BKNG180.02+1.78 (+1.00%) ▲|BLK964.15+2.59 (+0.27%) ▲|BMY57.22-0.40 (-0.69%) ▼|BNY145.09+0.48 (+0.33%) ▲|BRK-B500.49+0.10 (+0.02%) ▲|C139.12-0.84 (-0.60%) ▼|CAT1,038.13-26.77 (-2.51%) ▼|CL91.78+0.10 (+0.11%) ▲|CMCSA24.00-0.56 (-2.26%) ▼|COF202.06+1.44 (+0.72%) ▲|COP104.00+0.04 (+0.04%) ▲|COST925.00-10.47 (-1.12%) ▼|CRM163.56+6.90 (+4.40%) ▲|CSCO116.72-0.74 (-0.63%) ▼|CVS103.58+0.13 (+0.13%) ▲|CVX166.48+0.72 (+0.43%) ▲|DE625.06-9.27 (-1.46%) ▼|DHR191.76+1.28 (+0.67%) ▲|DIS97.00+0.75 (+0.77%) ▲|DUK126.33-0.25 (-0.20%) ▼|EMR141.55-1.61 (-1.12%) ▼|FDX315.28+2.15 (+0.69%) ▲|GD359.74+5.50 (+1.55%) ▲|GE374.75+1.02 (+0.27%) ▲|GEV1,151.69-23.17 (-1.97%) ▼|GILD125.78-0.56 (-0.44%) ▼|GM77.20+0.12 (+0.16%) ▲|GOOG353.82+0.49 (+0.14%) ▲|GOOGL357.16-0.22 (-0.06%) ▼|GS1,016.00+4.63 (+0.46%) ▲|HD354.31+1.63 (+0.46%) ▲|HON224.85+0.95 (+0.42%) ▲|IBM286.68+5.47 (+1.95%) ▲|INTC135.25-4.38 (-3.14%) ▼|INTU270.82+9.82 (+3.76%) ▲|ISRG401.82+4.14 (+1.04%) ▲|JNJ252.95-1.02 (-0.40%) ▼|JPM328.29+0.96 (+0.29%) ▲|KO81.62+0.35 (+0.42%) ▲|LIN519.07+0.13 (+0.02%) ▲|LLY1,195.38-4.05 (-0.34%) ▼|LMT518.83+9.37 (+1.84%) ▲|LOW223.16+2.67 (+1.21%) ▲|LRCX408.21-25.12 (-5.80%) ▼|MA514.50+0.90 (+0.18%) ▲|MCD269.55-0.76 (-0.28%) ▼|MDLZ58.72+0.88 (+1.52%) ▲|MDT79.54+1.31 (+1.67%) ▲|META604.43+41.14 (+7.30%) ▲|MMM160.68-1.23 (-0.76%) ▼|MO72.15+0.20 (+0.28%) ▲|MRK126.86-1.64 (-1.28%) ▼|MS209.85+0.81 (+0.39%) ▲|MSFT376.53+3.51 (+0.94%) ▲|MU1,089.58-64.71 (-5.61%) ▼|NEE87.36-0.37 (-0.42%) ▼|NFLX72.72+1.32 (+1.85%) ▲|NKE42.12+1.08 (+2.62%) ▲|NOW102.66+3.39 (+3.41%) ▲|NVDA195.25-4.84 (-2.42%) ▼|ORCL145.70-0.96 (-0.65%) ▼|PEP139.18+3.78 (+2.79%) ▲|PFE24.11+0.33 (+1.37%) ▲|PG146.41-0.11 (-0.08%) ▼|PLTR123.25+6.58 (+5.64%) ▲|PM179.11-1.74 (-0.96%) ▼|QCOM184.51-0.29 (-0.15%) ▼|RTX189.98+0.32 (+0.17%) ▲|SBUX102.45+0.26 (+0.25%) ▲|SCHW93.35+1.15 (+1.25%) ▲|SO95.66-0.03 (-0.03%) ▼|SPG221.57-2.15 (-0.96%) ▼|T20.81+0.12 (+0.56%) ▲|TMO505.28+4.37 (+0.87%) ▲|TMUS170.88+3.15 (+1.88%) ▲|TSLA422.87+2.27 (+0.54%) ▲|TXN302.33+4.26 (+1.43%) ▲|UBER72.75+0.64 (+0.89%) ▲|UNH418.13+2.78 (+0.67%) ▲|UNP272.74+0.84 (+0.31%) ▲|UPS108.25+0.85 (+0.79%) ▲|USB60.96+0.55 (+0.90%) ▲|V342.20-0.39 (-0.11%) ▼|VZ42.38+0.07 (+0.17%) ▲|WFC84.21+1.57 (+1.90%) ▲|WMT107.91-5.35 (-4.72%) ▼|XOM137.00+0.52 (+0.38%) ▲|
24.8 C
New York
Wednesday, July 1, 2026

Tag: reports

Grupo Aeroportuario del Pacifico Announces Results for the Second Quarter of 2025

GUADALAJARA, Mexico, July 21, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) reports its consolidated results for the second quarter ended June 30, 2025 (2Q25). Figures are unaudited and prepared following International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).

Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025

CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced upcoming scientific presentations at the 2025 Alzheimer’s Association International Conference (AAIC), taking place July 27-31 in Toronto, Canada. Data on LEQEMBI® (lecanemab) will include 48-month results from the Clarity AD open-label extension, real-world evidence, and new insights into a subcutaneous formulation for maintenance dosing. Presentations on tau will explore tau-targeted therapies and biomarkers, including baseline characteristics of participants from CELIA, a Phase 2 trial evaluating the efficacy, safety, and tolerability of BIIB080, an investigational antisense oligonucleotide (ASO) therapy that targets tau.

CHAMPION IRON ENTERS INTO A DEFINITIVE AGREEMENT WITH NIPPON STEEL AND SOJITZ TO FORM A PARTNERSHIP FOR THE KAMI PROJECT

MONTRÉAL, July 21, 2025 /CNW/ - SYDNEY, July 22, 2025 - Champion Iron Limited (TSX: CIA) (ASX: CIA) (OTCQX: CIAFF) ("Champion" or the "Company") announces...

Centene Corporation (CNC) Faces Shareholder Ire Amidst Plummeting Stock and Lawsuit Over “Inflated Guidance” – Hagens Berman

SAN FRANCISCO, July 21, 2025 (GLOBE NEWSWIRE) -- Healthcare giant Centene Corporation (NYSE: CNC), a prominent provider of government-sponsored and commercial healthcare services, finds itself embroiled in a class action lawsuit following a dramatic plunge in its stock price. The suit, Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.), seeks to represent investors who purchased or acquired Centene securities between December 12, 2024, and June 30, 2025, alleging violations of the Securities Exchange Act of 1934.

Group Eleven Announces C$5M Bought Deal Private Placement

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. NOT AN OFFER OF SECURITIES FOR SALE IN THE...

Interleukin-17 Inhibitors Market to Witness Strong Growth During the Forecast Period (2020-2034) Driven by Expanding Indications and Therapeutic Innovation | DelveInsight

The interleukin-17 inhibitors market is expected to remain strong in rheumatology (psoriasis and arthritis), with potential expansion into hidradenitis suppurativa and other dermatologic conditions....

Interleukin-17 Inhibitors Market to Witness Strong Growth During the Forecast Period (2020-2034) Driven by Expanding Indications and Therapeutic Innovation | DelveInsight

The interleukin-17 inhibitors market is expected to remain strong in rheumatology (psoriasis and arthritis), with potential expansion into hidradenitis suppurativa and other dermatologic conditions....

Pixalate’s June 2025 Delisted Mobile Apps Reports: 46,331 Apps Delisted from Google Play Store & 45,685 from Apple App Store

Pixalate research finds 12,790 apps delisted from the United States (U.S.) Google Play Store were ad-enabled (e.g., had an app-ads.txt file), while 3,789 apps delisted from the Apple App Store were ad-enabled
Pixalate research finds 12,790 apps delisted from the United States (U.S.) Google Play Store were ad-enabled (e.g., had an app-ads.txt file), while 3,789 apps delisted from the Apple App Store were ad-enabled

ELS Reports Second Quarter Results

Continued Strong Performance CHICAGO, July 21, 2025  /PRNewswire/ -- Equity LifeStyle Properties, Inc. (NYSE: ELS) (referred to herein as "we," "us," and "our") today announced...

PSEG Declares Regular Quarterly Dividend for the Third Quarter of 2025

NEWARK, N.J., July 21, 2025 /PRNewswire/ -- The Board of Directors of Public Service Enterprise Group (NYSE: PEG) today declared a $0.63 per share...

2024 AI and IoT Technology Market Review: Insights from BCC Research

"This research review highlights the transformative impact of artificial intelligence (AI) and the Internet of Things (IoT) across industriindustries, showcasing significant market growth, technological...

NAV CANADA reports June 2025 traffic figure

OTTAWA, ON, July 21, 2025 /CNW/ - NAV CANADA announced today its traffic figure for the month of June 2025 as measured in weighted...

Industrial Floor Mats Market Size to Grow USD 3987.1 Million by 2030 at a CAGR of 2.3% | Valuates Reports

BANGALORE, India, July 21, 2025 /PRNewswire/ -- Industrial Floor Mats Market is Segmented by Type (Anti-fatigue Mats, Anti-static Mats, Traction Mats, Non-conductive Mats), by...

KPN reports on progress of € 250m share buyback

KPN has repurchased 1,533,000 KPN ordinary shares in the period from 14 July to 18 July 2025. The shares were repurchased at an average price of € 4.09 per share for a total consideration of € 6.3m. These repurchases are part of the € 250m share buyback started on 25 February 2025 and reflect KPN's commitment to structurally return additional capital to its shareholders.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsReports